首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

1547937

全球真實世界證據解決方案市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Real World Evidence Solutions Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年07月01日 | 出版商:

Value Market Research | 英文 172 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球真實世界證據解決方案市場需求預計將從 2023 年的 29.5 億美元達到近 57.3 億美元的市場規模，2024-2032 年研究期間複合年成長率為 7.65%。

真實世界證據是在隨機對照試驗的背景下從現實世界收集觀察資料的概念。這些資料是在常規臨床實踐過程中產生的，用於評估患者的結果。該記錄儲存在電子健康記錄、行動裝置、計費活動資料庫等。的藥物。

市場動態

真實世界證據在監測上市後安全和不良事件的醫療保健決策中發揮重要作用。醫療保健產品開發商正在使用 RWE 來支援旨在產生新治療方法的觀察研究和臨床試驗。不斷成長的醫療保健和臨床試驗正在推動市場的成長。製藥業正在投資該市場，透過社群媒體和電子醫療設備提供觀察性研究、以患者為中心的研究活動，以提升患者體驗。儘管是臨床研究的主要貢獻者，RWE 仍面臨資料可用性、不同的 EMR 系統、品質和精確度問題以及治理問題等挑戰。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對現實世界證據解決方案全球市場的每個細分市場進行包容性評估。真實世界證據解決方案產業的成長和趨勢為本研究提供了整體方法。

市場區隔

真實世界證據解決方案市場報告的這一部分提供了有關國家和區域級別細分市場的詳細資料，從而幫助策略師確定相應產品或服務的目標人口統計數據以及即將到來的機會。

按組件

服務
資料集
臨床設定數據
索賠數據
藥房數據
患者驅動的數據

按申請

藥物開發與核准
醫療器材開發與核准
報銷/覆蓋範圍和監管決策
上市後安全與不良事件監測

按最終用途

醫療保健公司
醫療保健提供者
醫療保健支付者
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲真實世界證據解決方案市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。現實世界證據解決方案市場的主要參與者包括 IQVIA、IBM、PPD Inc.、Parexel International Corporation、PerkinElmer Inc.、Icon Plc、Oracle、Syneos Health、Cegedim Health Data、Medpace Others。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：現實世界證據解決方案公司的競爭格局

真實世界證據解決方案市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

頂級公司市佔率分析
市場集中度
IQVIA

公司概況
公司收入
產品
最新動態

公司概況
公司收入
產品
最新動態

PPD Inc.

公司概況
公司收入
產品
最新動態

Parexel International Corporation

公司概況
公司收入
產品
最新動態

PerkinElmer Inc.

公司概況
公司收入
產品
最新動態

Icon Plc

公司概況
公司收入
產品
最新動態

Oracle

公司概況
公司收入
產品
最新動態

Syneos Health

公司概況
公司收入
產品
最新動態

Cegedim Health Data

公司概況
公司收入
產品
最新動態

Medpace Others

公司概況
公司收入
產品
最新動態

註 - 在公司概況中，財務詳細資訊和最新發展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR11212359

The global demand for Real World Evidence Solutions Market is presumed to reach the market size of nearly USD 5.73 Billion by 2032 from USD 2.95 Billion in 2023 with a CAGR of 7.65% under the study period 2024-2032.

Real-world evidence is a concept of collecting observational data from real-world outside the context of a randomised controlled trial. The data is generated during routine clinical practice to assess the patient's outcome. The record is stored in electronic health records, mobile devices, billing activities databases, etc. The RWE play a critical role in health and clinical studies, provides a solution to the problem, understands the patient pathway to deliver the appropriate care and also analyse effects of drugs during a timespan.

MARKET DYNAMICS

Real-World Evidence plays an essential role in health care decisions to monitor postmarket safety and adverse events. Healthcare product developers are using RWE to support observational studies and clinical trial designed to generate new treatment approaches. Growing healthcare and clinical trials are driving the growth of the market. Pharmaceutical industries are investing in the market to boost patients experience by providing observational studies, patient-centred research activities through social media and selectronic medical devices. Despite being a major contributor to clinical research, RWE faces challenges such as availability of data, different EMR system, concerns about quality and precision and governance issues.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Real World Evidence Solutions. The growth and trends of Real World Evidence Solutions industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Real World Evidence Solutions market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Component

Services
Data Sets
Clinical Settings Data
Claims Data
Pharmacy Data
Patient-Powered Data

By Application

Drug Development & Approvals
Medical Device Development & Approvals
Reimbursement/Coverage & Regulatory Decision Making
Post Market Safety & Adverse Events Monitoring

By End-use

Healthcare Companies
Healthcare Providers
Healthcare Payers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Real World Evidence Solutions market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Real World Evidence Solutions market include IQVIA, IBM, PPD Inc., Parexel International Corporation, PerkinElmer Inc., Icon Plc, Oracle, Syneos Health, Cegedim Health Data, Medpace Others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. REAL WORLD EVIDENCE SOLUTIONS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By End-use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY COMPONENT

5.1. Overview By Component
5.2. Historical and Forecast Data
5.3. Analysis By Component
5.4. Services Historic and Forecast Sales By Regions
5.5. Data Sets Historic and Forecast Sales By Regions
5.6. Clinical Settings Data Historic and Forecast Sales By Regions
5.7. Claims Data Historic and Forecast Sales By Regions
5.8. Pharmacy Data Historic and Forecast Sales By Regions
5.9. Patient-Powered Data Historic and Forecast Sales By Regions

6. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. Drug Development & Approvals Historic and Forecast Sales By Regions
6.5. Medical Device Development & Approvals Historic and Forecast Sales By Regions
6.6. Reimbursement/Coverage & Regulatory Decision Making Historic and Forecast Sales By Regions
6.7. Post Market Safety & Adverse Events Monitoring Historic and Forecast Sales By Regions

7. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY END-USE

7.1. Overview By End-use
7.2. Historical and Forecast Data
7.3. Analysis By End-use
7.4. Healthcare Companies Historic and Forecast Sales By Regions
7.5. Healthcare Providers Historic and Forecast Sales By Regions
7.6. Healthcare Payers Historic and Forecast Sales By Regions
7.7. Others Historic and Forecast Sales By Regions

8. GLOBAL REAL WORLD EVIDENCE SOLUTIONS MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE REAL WORLD EVIDENCE SOLUTIONS COMPANIES

9.1. Real World Evidence Solutions Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF REAL WORLD EVIDENCE SOLUTIONS INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. IQVIA
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. IBM
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. PPD Inc.
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. Parexel International Corporation
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. PerkinElmer Inc.
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Icon Plc
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Oracle
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Syneos Health
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Cegedim Health Data
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Medpace Others
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

簡介目錄圖表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Component (USD MN)
Services Market Sales By Geography (USD MN)
Data Sets Market Sales By Geography (USD MN)
Clinical Settings Data Market Sales By Geography (USD MN)
Claims Data Market Sales By Geography (USD MN)
Pharmacy Data Market Sales By Geography (USD MN)
Patient-Powered Data Market Sales By Geography (USD MN)
Analysis By Application (USD MN)
Drug Development & Approvals Market Sales By Geography (USD MN)
Medical Device Development & Approvals Market Sales By Geography (USD MN)
Reimbursement/Coverage & Regulatory Decision Making Market Sales By Geography (USD MN)
Post Market Safety & Adverse Events Monitoring Market Sales By Geography (USD MN)
Analysis By End-use (USD MN)
Healthcare Companies Market Sales By Geography (USD MN)
Healthcare Providers Market Sales By Geography (USD MN)
Healthcare Payers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Real World Evidence Solutions Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Real World Evidence Solutions Report
Market Research Process
Market Research Methodology
Global Real World Evidence Solutions Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Component
Market Attractiveness Analysis By Application
Market Attractiveness Analysis By End-use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Component (USD MN)
Services Market Sales By Geography (USD MN)
Data Sets Market Sales By Geography (USD MN)
Clinical Settings Data Market Sales By Geography (USD MN)
Claims Data Market Sales By Geography (USD MN)
Pharmacy Data Market Sales By Geography (USD MN)
Patient-Powered Data Market Sales By Geography (USD MN)
Global Market Analysis By Application (USD MN)
Drug Development & Approvals Market Sales By Geography (USD MN)
Medical Device Development & Approvals Market Sales By Geography (USD MN)
Reimbursement/Coverage & Regulatory Decision Making Market Sales By Geography (USD MN)
Post Market Safety & Adverse Events Monitoring Market Sales By Geography (USD MN)
Global Market Analysis By End-use (USD MN)
Healthcare Companies Market Sales By Geography (USD MN)
Healthcare Providers Market Sales By Geography (USD MN)
Healthcare Payers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis